At the virtual Great Debates & Updates in Hematologic Malignancies, S. Vincent Rajkumar, MD, discussed the frontline therapy of MM for transplant-ineligible patients.
During the virtual Great Debates & Updates in Hematologic Malignancies, Dr Pemmaraju discussed new therapies for myeloproliferative neoplasms (MPNs) with a focus on CMML.
At the virtual Great Debates & Updates in Hematologic Malignancies, Dr Mikhael presented emerging therapies in multiple myeloma (MM).
At the virtual Great Debates & Updates in Hematologic Malignancies, Jonathon Cohen, MD, presented standard treatment regiments and novel agents for the treatment of MCL.
Dr Jabbour discusses his presentation from the virtual Great Debates and Updates in Hematologic Malignancies on the management of patients with Ph+ and Ph-like ALL.
At the virtual Great Debates & Updates in Hematologic Malignancies, Michael Mauro, MD, presented on practical approaches for monitoring patients with CML as per NCCN and ELN recommendations.
During the Great Debates & Updates in Hematologic Malignancies, Gail Roboz, MD, discussed how clinicians can lead patients with AML down the correct treatment path.
At the virtual Great Debates & Updates in Hematologic Malignancies, Jonathan Kaufman, MD, discussed the standard front-line approach for treating patients with MM ineligible for transplantation.
Stay in the know.
OncNet Newsletter